Skip to main content

Table 5 Frequency distribution of all adverse events reported after surgery

From: Prospective, open, multi-centre phase I/II trial to assess safety and efficacy of neoadjuvant radiochemotherapy with docetaxel and oxaliplatin in patients with adenocarcinoma of the oesophagogastric junction

 

Dose level

 

Event

1

2

3

Total

Number of patients

3 (100%)

11 (100%)

4 (100%)

18 (100%)

 Any event

1 (33%)

2 (18%)

1 (25%)

4 (22%)

 Pericardial effusion

  

1 (25%)

1 (6%)

 Fever

1 (33%)

  

1 (6%)

 Infection

 

1 (9%)

 

1 (6%)

 Pleural effusion

 

1 (9%)

 

1 (6%)